IL27 and prostate cancer: In addition, IL-30 stimulated proliferation of human prostate cancer cells, which express both IL-6Rα and gp130, and downregulated the expression of chemokines, such as CCL16, tumor necrosis factor superfamily member 14, and chemokine-like factor, which recruit immune cells into the tumor (68).